Racial disparities in patients diagnosed with light chain (AL) amyloidosis

Racial disparities in patients diagnosed with light chain (AL) amyloidosis

Bibliographic Details
Main Authors:	Anita D’Souza, Liliana Pezzin, Purushottam Laud, Ashima Singh
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-04-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-021-00466-8

Similar Items

Localized Lymph Node Light Chain Amyloidosis
by: Binod Dhakal, et al.
Published: (2015-01-01)

Retinitis pigmentosa associated with systemic light chain amyloidosis (AL amyloidosis)
by: Salem Bouomrani, et al.
Published: (2021-04-01)

Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
by: Giovanni Palladini, et al.
Published: (2021-03-01)

Acquired factor X deficiency in light-chain (AL) amyloidosis is rare and associated with advanced disease
by: Gina Patel, et al.
Published: (2019-03-01)

LIGHT CHAIN AMYLOIDOSIS
by: Paolo Milani, et al.
Published: (2018-03-01)

Recent advances in understanding and treating immunoglobulin light chain amyloidosis [version 1; referees: 2 approved]
by: Talha Badar, et al.
Published: (2018-08-01)

Light chain (AL) amyloidosis: update on diagnosis and management
by: Rosenzweig Michael, et al.
Published: (2011-11-01)

Light-Chain Cardiac Amyloidosis
by: Gonzalo Barge-Caballero, MD, et al.
Published: (2019-10-01)

Presence of fluorescent in situ hybridization abnormalities is associated with plasma cell burden in light chain amyloidosis
by: Lindsay Hammons, et al.
Published: (2018-06-01)

Differences in immunoglobulin light chain species found in urinary exosomes in light chain amyloidosis (Al).
by: Marina Ramirez-Alvarado, et al.
Published: (2012-01-01)

Pseudoxanthoma Elasticum and Light-Chain Amyloidosis
by: M. Carlesimo, et al.
Published: (2012-09-01)

DUAL expectations in light chain amyloidosis
by: Stefan Schönland, et al.
Published: (2020-07-01)

Novel Therapies in Light Chain Amyloidosis
by: Paolo Milani, et al.
Published: (2018-05-01)

Changes in patient-reported outcomes in light chain amyloidosis in the first year after diagnosis and relationship to NT-proBNP change
by: Anita D’Souza, et al.
Published: (2021-02-01)

Multiple myeloma and light-chain amyloidosis: a rare presentation
by: carmenza Liliana Sandoval, et al.
Published: (2018-07-01)

Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis.
by: Tanya L Poshusta, et al.
Published: (2009-01-01)

Racial Disparities in Health Risk Indicators Reported by Alabamians Diagnosed with COPD
by: Michael Stellefson, et al.
Published: (2021-09-01)

Autopsy findings in a patient with primary systemic AL (kappa light chain) amyloidosis
by: Felipe Lourenço Ledesma, et al.
Published: (2021-05-01)

The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
by: Emilia Czyżewska, et al.
Published: (2021-03-01)

Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis
by: Anita D'Souza, et al.
Published: (2017-12-01)

Light chain amyloidosis presenting as retiform purpura
by: Yssra S. Soliman, MD, et al.
Published: (2021-06-01)

A case of systemic light - chain amyloidosis
by: ZHOU Qi, et al.
Published: (2018-03-01)

Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis
by: Sadichhya Lohani, et al.
Published: (2016-01-01)

Progressive chorioretinal involvement in a patient with light-chain (AL) amyloidosis: a case report
by: Edouard Augstburger, et al.
Published: (2020-02-01)

Treatment Options For Relapsed/refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives
by: Sarosiek S, et al.
Published: (2019-10-01)

Dissecting the Molecular Features of Systemic Light Chain (AL) Amyloidosis: Contributions from Proteomics
by: Paola Rognoni, et al.
Published: (2021-08-01)

Beyond Andromeda: Improving Therapy for Light Chain Amyloidosis
by: Gregory P. Kaufman, et al.
Published: (2021-02-01)

Magnetic Resonance Elastography of Liver in Light Chain Amyloidosis
by: Sudhakar K. Venkatesh, et al.
Published: (2019-05-01)

Systemic Light Chain Amyloidosis Mimicking Rheumatic Disorders
by: Rohit R. Rao, et al.
Published: (2016-01-01)

Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis
by: Kathleen W. Zhang, MD, et al.
Published: (2019-06-01)

Light-Chain Amyloidosis With Peripheral Neuropathy as an Initial Presentation
by: Min Qian, et al.
Published: (2021-09-01)

How I manage systemic light chain amyloidosis
by: Gregory P. Kaufman, et al.
Published: (2021-09-01)

Pathogenesis of light chain-induced dysfunction in cardiac amyloidosis
by: Snyder, Christina AnnaMarie
Published: (2016)

Localized Immunoglobulin Light-Chain Amyloidosis of the Ulnar Nerve
by: Shinsuke Morisaki, et al.
Published: (2021-05-01)

Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient
by: Paolo Swuec, et al.
Published: (2019-03-01)

Diverse patterns of antibody variable gene repertoire disruption in patients with amyloid light chain (AL) amyloidosis.
by: Elaine C Chen, et al.
Published: (2020-01-01)

The concurrence of light-chain deposition disease, AL-amyloidosis, and cast nephropathy in a patient with multiple myeloma
by: I G Rekhtina, et al.
Published: (2015-06-01)

Racial Disparity Among Women Diagnosed With Invasive Breast Cancer in a Large Integrated Health System
by: Maharaj Singh, et al.
Published: (2018-07-01)

Acquired Factor X Deficiency in Patients With Primary Light Chain Amyloidosis
by: Siroj Dejhansathit MD, et al.
Published: (2019-03-01)

Evidence of Concurrent Light Chain and Transthyretin Cardiac Amyloidosis in 2 Patients
by: Joseph P. Donnelly, MD, et al.
Published: (2020-03-01)